Cipla

New Delhi: Drugs Controller General of India (DCGI) has given Cipla approval to import Moderna's COVID-19 vaccine for restricted emergency use in the country. Moderna’s COVID-19 vaccine will be the fourth vaccine to be administered…

Cipla Limited has entered into a partnership with Premier Medical Corporation Private Limited for the commercialisation of the rapid antigen test kits to detect COVID 19 in India. The company will start supplying the kits that will detect…

New Delhi: Leading pharmaceutical company Cipla has sought permission to launch Favipiravir, an anti-viral drug, in India to fight against COVID-19. Sources said the Council of Scientific and Industrial Research (CSIR) had developed an…

Bengaluru: Indian drugmaker Cipla, has priced its generic version of Remdesivir, Cipremi at Rs 4,000 ($53.34) per 100 mg vial, making it among the lowest-priced versions of the COVID-19 treatment available so far globally, India Today…

New Delhi: Amid rising cases of coronavirus, there are reports about supply shortage and selling of two life-saving drugs — remdesivir and tocilizumab — for exorbitant rates on old Delhi's black market. The investigation reported by BBC…

Another anti-viral drug for the treatment of COVID-19 has been launched, this time by pharma major Cipla. To be sold in the market under the brand name of Cipremi, this one is a generic version of antiviral drug Remdesivir to be used in…